LEXEO THERAPEUTICS INC (LXEO)

US52886X1072 - Common Stock

6.2  +0.08 (+1.31%)

After market: 6.2 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to LXEO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 22.88. This target is 268.99% above the current price.
LXEO was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about LXEO.
In the previous month the buy percentage consensus was at a similar level.
LXEO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 6.2020.2021.4222.8829.40 - 225.81% 245.48% 268.99% 374.19%
Up and Down Grades
Date Firm Action Rating
2024-11-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-13 Leerink Partners Maintains Outperform -> Outperform
2024-11-13 Chardan Capital Maintains Buy -> Buy
2024-10-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-30 Chardan Capital Maintains Buy -> Buy
2024-10-25 Chardan Capital Maintains Buy -> Buy
2024-08-14 Chardan Capital Maintains Buy -> Buy
2024-08-13 RBC Capital Reiterate Outperform -> Outperform
2024-08-13 HC Wainwright & Co. Maintains Buy -> Buy
2024-07-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-15 Chardan Capital Maintains Buy -> Buy
2024-06-13 Baird Initiate Outperform
2024-06-06 HC Wainwright & Co. Initiate Buy
2024-03-12 RBC Capital Maintains Outperform -> Outperform
2023-11-28 Leerink Partners Initiate Outperform
2023-11-28 Chardan Capital Initiate Buy
2023-11-28 RBC Capital Initiate Outperform
2023-11-28 Stifel Initiate Buy
2023-11-28 JP Morgan Initiate Overweight